We have located links that may give you full text access.
A Complete Response of Orbital Metastases in Breast Cancer Patient Treated with Oral Chemotherapy: Case Report and Literature Review.
Case Reports in Oncology 2022 January
Discrete extraocular muscles (EOMs) metastases are extremely rare events. Here is a case of isolated orbital metastases involving EOMs in a female patient who was previously diagnosed with triple-negative breast cancer. She received chemotherapy followed by radiotherapy. Years later, the patient complained of gradually progressive ptosis of the right eye that was associated with mild restriction of ocular movements. Magnetic resonance imaging showed a suspected metastatic lesion. An open biopsy was performed for pathological evaluation. Metastases from breast cancer were confirmed. Immunohistochemistry showed discordance of the estrogen and progesterone receptors. She received oral capecitabine (Xeloda® ) and vinorelbine (NVB) followed by hormone therapy. At the time of reporting, our patient remained in remission for 28 months as from her initial diagnosis of orbital metastases.
Full text links
Related Resources
Trending Papers
Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows.Endocrine Reviews 2024 April 28
The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment Options: A Scientific Statement From the American Heart Association.Circulation 2024 April 26
Intravenous infusion of dexmedetomidine during the surgery to prevent postoperative delirium and postoperative cognitive dysfunction undergoing non-cardiac surgery: a meta-analysis of randomized controlled trials.European Journal of Medical Research 2024 April 19
Interstitial Lung Disease: A Review.JAMA 2024 April 23
Ventilator Waveforms May Give Clues to Expiratory Muscle Activity.American Journal of Respiratory and Critical Care Medicine 2024 April 25
Acute Kidney Injury and Electrolyte Imbalances Caused by Dapagliflozin Short-Term Use.Pharmaceuticals 2024 March 27
Systemic lupus erythematosus.Lancet 2024 April 18
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app